People older than 80 who waited 11 to 12 weeks for their second jab had higher peak antibody levels than did those who waited only three weeks -- Read more on ScientificAmerican.com
Pfizer-BioNTech vaccine approval is younger teens’ shot at freedom -- Read more on ScientificAmerican.com
Hopes were high for drugs designed to lower levels of a mutant protein, but development has stalled -- Read more on ScientificAmerican.com
The development from the Biden administration draws cheers from public health researchers and ire from drugmakers -- Read more on ScientificAmerican.com
Clear messaging and transparency are vital, say some experts on risk assessment and decision-making -- Read more on ScientificAmerican.com
Next-generation COVID-19 vaccines will not only tackle different versions of the virus but will provide solutions across the world at a fraction of the cost -- Read more on ScientificAmerican.com
The new DNA-based test predicts transplant rejection -- Read more on ScientificAmerican.com
Preliminary results suggest the vaccine is up to 77 percent effective in young children, but researchers await larger studies -- Read more on ScientificAmerican.com
It was lysozyme, an enzyme that attacks the cell walls of bacteria—and just as with the celebrated antibiotic, he found it through pure serendipity -- Read more on ScientificAmerican.com
Infectious disease physician-scientist Wilbur Chen discusses the rare cases of blood clots linked to the immunization -- Read more on ScientificAmerican.com
For the first time, a randomized controlled trial shows the psychedelic offers potent, if short-term, relief in comparison with an SSRI -- Read more on ScientificAmerican.com
An infectious disease doctor answers questions about the CDC’s and FDA’s decision to pause the vaccine’s use over a possible link with blood clots -- Read more on ScientificAmerican.com
Researchers are searching for possible links between unusual clotting and the Oxford-AstraZeneca coronavirus vaccine -- Read more on ScientificAmerican.com
Pulmonary fibrosis is diagnosed in about 50,000 new patients annually, and as many as 40,000 Americans die from it each year -- Read more on ScientificAmerican.com
The pandemic has spotlighted ways to make clinical trials easier on patients and better for science, a heart drug researcher says -- Read more on ScientificAmerican.com
Reactions reflect unique features of an individual’s immune system, not the strength of a response -- Read more on ScientificAmerican.com